Logo image of HOMI.BR

HOME INVEST BELGIUM (HOMI.BR) Stock Fundamental Analysis

EBR:HOMI - Euronext Brussels - BE0974409410 - REIT - Currency: EUR

20  +0.22 (+1.11%)

Fundamental Rating

5

Overall HOMI gets a fundamental rating of 5 out of 10. We evaluated HOMI against 6 industry peers in the Residential REITs industry. HOMI scores excellent on profitability, but there are concerns on its financial health. HOMI has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year HOMI was profitable.
HOMI had a positive operating cash flow in the past year.
Of the past 5 years HOMI 4 years were profitable.
In the past 5 years HOMI always reported a positive cash flow from operatings.
HOMI.BR Yearly Net Income VS EBIT VS OCF VS FCFHOMI.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

1.2 Ratios

HOMI has a better Return On Assets (8.99%) than 100.00% of its industry peers.
HOMI has a Return On Equity of 16.71%. This is amongst the best in the industry. HOMI outperforms 100.00% of its industry peers.
HOMI has a Return On Invested Capital of 2.36%. This is in the lower half of the industry: HOMI underperforms 66.67% of its industry peers.
HOMI had an Average Return On Invested Capital over the past 3 years of 2.36%. This is in line with the industry average of 3.41%.
The 3 year average ROIC (2.36%) for HOMI is below the current ROIC(2.36%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.99%
ROE 16.71%
ROIC 2.36%
ROA(3y)4.75%
ROA(5y)4.76%
ROE(3y)9.08%
ROE(5y)9.52%
ROIC(3y)2.36%
ROIC(5y)2.27%
HOMI.BR Yearly ROA, ROE, ROICHOMI.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

1.3 Margins

Looking at the Profit Margin, with a value of 221.81%, HOMI belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Profit Margin of HOMI has remained more or less at the same level.
The Operating Margin of HOMI (76.47%) is better than 83.33% of its industry peers.
In the last couple of years the Operating Margin of HOMI has grown nicely.
The Gross Margin of HOMI (92.87%) is better than 100.00% of its industry peers.
In the last couple of years the Gross Margin of HOMI has remained more or less at the same level.
Industry RankSector Rank
OM 76.47%
PM (TTM) 221.81%
GM 92.87%
OM growth 3Y2.45%
OM growth 5Y3.82%
PM growth 3Y7.72%
PM growth 5Y0.13%
GM growth 3Y0.61%
GM growth 5Y0.41%
HOMI.BR Yearly Profit, Operating, Gross MarginsHOMI.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HOMI is destroying value.
HOMI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, HOMI has more shares outstanding
Compared to 1 year ago, HOMI has an improved debt to assets ratio.
HOMI.BR Yearly Shares OutstandingHOMI.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
HOMI.BR Yearly Total Debt VS Total AssetsHOMI.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 0.86, we must say that HOMI is in the distress zone and has some risk of bankruptcy.
HOMI's Altman-Z score of 0.86 is amongst the best of the industry. HOMI outperforms 83.33% of its industry peers.
HOMI has a Debt/Equity ratio of 0.82. This is a neutral value indicating HOMI is somewhat dependend on debt financing.
HOMI's Debt to Equity ratio of 0.82 is fine compared to the rest of the industry. HOMI outperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF N/A
Altman-Z 0.86
ROIC/WACC0.47
WACC5.01%
HOMI.BR Yearly LT Debt VS Equity VS FCFHOMI.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

HOMI has a Current Ratio of 0.31. This is a bad value and indicates that HOMI is not financially healthy enough and could expect problems in meeting its short term obligations.
HOMI has a worse Current ratio (0.31) than 66.67% of its industry peers.
HOMI has a Quick Ratio of 0.31. This is a bad value and indicates that HOMI is not financially healthy enough and could expect problems in meeting its short term obligations.
HOMI has a Quick ratio of 0.31. This is in the lower half of the industry: HOMI underperforms 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.31
Quick Ratio 0.31
HOMI.BR Yearly Current Assets VS Current LiabilitesHOMI.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

4

3. Growth

3.1 Past

HOMI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 616.03%, which is quite impressive.
Measured over the past 5 years, HOMI shows a small growth in Earnings Per Share. The EPS has been growing by 3.82% on average per year.
The Revenue has been growing slightly by 4.92% in the past year.
HOMI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.71% yearly.
EPS 1Y (TTM)616.03%
EPS 3Y11.06%
EPS 5Y3.82%
EPS Q2Q%1175.99%
Revenue 1Y (TTM)4.92%
Revenue growth 3Y9.86%
Revenue growth 5Y7.71%
Sales Q2Q%3.94%

3.2 Future

HOMI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.26% yearly.
Based on estimates for the next years, HOMI will show a small growth in Revenue. The Revenue will grow by 4.70% on average per year.
EPS Next Y2.16%
EPS Next 2Y2.78%
EPS Next 3Y2.26%
EPS Next 5YN/A
Revenue Next Year6.21%
Revenue Next 2Y5.26%
Revenue Next 3Y4.7%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HOMI.BR Yearly Revenue VS EstimatesHOMI.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
HOMI.BR Yearly EPS VS EstimatesHOMI.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 4.88, which indicates a rather cheap valuation of HOMI.
100.00% of the companies in the same industry are more expensive than HOMI, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of HOMI to the average of the S&P500 Index (27.24), we can say HOMI is valued rather cheaply.
A Price/Forward Earnings ratio of 16.62 indicates a correct valuation of HOMI.
HOMI's Price/Forward Earnings is on the same level as the industry average.
HOMI's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.42.
Industry RankSector Rank
PE 4.88
Fwd PE 16.62
HOMI.BR Price Earnings VS Forward Price EarningsHOMI.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HOMI is valued expensively inside the industry as 83.33% of the companies are valued cheaper.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 28.6
HOMI.BR Per share dataHOMI.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
HOMI has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.25
PEG (5Y)1.28
EPS Next 2Y2.78%
EPS Next 3Y2.26%

6

5. Dividend

5.1 Amount

HOMI has a Yearly Dividend Yield of 4.24%, which is a nice return.
HOMI's Dividend Yield is comparable with the industry average which is at 5.55.
Compared to an average S&P500 Dividend Yield of 2.40, HOMI pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.24%

5.2 History

The dividend of HOMI decreases each year by -8.56%.
Dividend Growth(5Y)-8.56%
Div Incr Years2
Div Non Decr Years2
HOMI.BR Yearly Dividends per shareHOMI.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

HOMI pays out 14.18% of its income as dividend. This is a sustainable payout ratio.
DP14.18%
EPS Next 2Y2.78%
EPS Next 3Y2.26%
HOMI.BR Yearly Income VS Free CF VS DividendHOMI.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M
HOMI.BR Dividend Payout.HOMI.BR Dividend Payout, showing the Payout Ratio.HOMI.BR Dividend Payout.PayoutRetained Earnings

HOME INVEST BELGIUM

EBR:HOMI (8/5/2025, 5:29:29 PM)

20

+0.22 (+1.11%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Earnings (Last)05-21 2025-05-21
Earnings (Next)09-03 2025-09-03
Inst Owners3.3%
Inst Owner ChangeN/A
Ins Owners3.23%
Ins Owner ChangeN/A
Market Cap404.00M
Analysts45.45
Price Target19.55 (-2.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.24%
Yearly Dividend0.58
Dividend Growth(5Y)-8.56%
DP14.18%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.65%
Revenue NY rev (3m)0.65%
Valuation
Industry RankSector Rank
PE 4.88
Fwd PE 16.62
P/S 11.07
P/FCF N/A
P/OCF 18.65
P/B 0.83
P/tB 0.83
EV/EBITDA 28.6
EPS(TTM)4.1
EY20.5%
EPS(NY)1.2
Fwd EY6.02%
FCF(TTM)-0.72
FCFYN/A
OCF(TTM)1.07
OCFY5.36%
SpS1.81
BVpS23.98
TBVpS23.95
PEG (NY)2.25
PEG (5Y)1.28
Profitability
Industry RankSector Rank
ROA 8.99%
ROE 16.71%
ROCE 3.15%
ROIC 2.36%
ROICexc 2.37%
ROICexgc 2.37%
OM 76.47%
PM (TTM) 221.81%
GM 92.87%
FCFM N/A
ROA(3y)4.75%
ROA(5y)4.76%
ROE(3y)9.08%
ROE(5y)9.52%
ROIC(3y)2.36%
ROIC(5y)2.27%
ROICexc(3y)2.37%
ROICexc(5y)2.29%
ROICexgc(3y)2.37%
ROICexgc(5y)2.29%
ROCE(3y)3.14%
ROCE(5y)3.03%
ROICexcg growth 3Y3.18%
ROICexcg growth 5Y3%
ROICexc growth 3Y3.18%
ROICexc growth 5Y3%
OM growth 3Y2.45%
OM growth 5Y3.82%
PM growth 3Y7.72%
PM growth 5Y0.13%
GM growth 3Y0.61%
GM growth 5Y0.41%
F-Score6
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF N/A
Debt/EBITDA 14.18
Cap/Depr 18429.6%
Cap/Sales 98.95%
Interest Coverage 2.37
Cash Conversion 77.04%
Profit Quality N/A
Current Ratio 0.31
Quick Ratio 0.31
Altman-Z 0.86
F-Score6
WACC5.01%
ROIC/WACC0.47
Cap/Depr(3y)6185.6%
Cap/Depr(5y)5158.09%
Cap/Sales(3y)33.41%
Cap/Sales(5y)31.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)616.03%
EPS 3Y11.06%
EPS 5Y3.82%
EPS Q2Q%1175.99%
EPS Next Y2.16%
EPS Next 2Y2.78%
EPS Next 3Y2.26%
EPS Next 5YN/A
Revenue 1Y (TTM)4.92%
Revenue growth 3Y9.86%
Revenue growth 5Y7.71%
Sales Q2Q%3.94%
Revenue Next Year6.21%
Revenue Next 2Y5.26%
Revenue Next 3Y4.7%
Revenue Next 5YN/A
EBIT growth 1Y10.54%
EBIT growth 3Y12.55%
EBIT growth 5Y11.82%
EBIT Next Year-44.61%
EBIT Next 3Y-15.54%
EBIT Next 5YN/A
FCF growth 1Y-156.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-15.55%
OCF growth 3Y5.42%
OCF growth 5Y7.98%